Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Dynavax Technologies
Dynavax Technologies

Dynavax Technologies

Public

Dynavax, a US biopharmaceutical firm, develops and markets novel vaccines, including a hepatitis B vaccine and COVID-19 research.

HQ
Berkeley, CA, US
Founded
1996
Overview
Compare
Fundraising
Employees

Dynavax Technologies, founded in Berkeley, United States, is a commercial-stage biopharmaceutical company committed to developing and commercializing novel vaccines aimed at preventing infectious diseases. The company's core mission is to protect global health through innovative adjuvant technology. Dynavax's flagship product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], is approved in the U.S. and the European Union for adults aged 18 and older. Additionally, Dynavax is advancing its CpG 1018™ adjuvant through various research collaborations and partnerships.

Notable figures associated with Dynavax include its dedicated team of scientists and executives who drive its mission forward. The company has garnered significant investment and support from the biopharmaceutical community. Key achievements include the successful commercialization of HEPLISAV-B® and the development of CpG 1018™ as a premier vaccine adjuvant. Dynavax's impact is marked by its contributions to public health, particularly in the prevention of hepatitis B and other infectious diseases through its innovative vaccine solutions.

Dynavax Technologies - Similar Companies

Novavax logo

Novavax

novavax.com

PaxVax logo

PaxVax

Adjuvance Technologies logo

Adjuvance Technologies

Sinovac Biotech logo

Sinovac Biotech

Arbovax logo

Arbovax

Pathovax logo

Pathovax

pathovax.com

Centivax logo

Centivax

centivax.com

Altravax logo

Altravax

altravax.com

Agilvax logo

Agilvax

Bioscience Vaccines logo

Bioscience Vaccines

Vaxform logo

Vaxform

vaxform.com

Uvax Bio logo

Uvax Bio

uvaxbio.com

NeuImmune logo

NeuImmune

neuimmune.com

Thyreos logo

Thyreos

X-Vax Technology logo

X-Vax Technology

Dynavax Technologies - Quick Facts

Who are Dynavax Technologies' competitors?

Companies similar to Dynavax Technologies include Novavax, PaxVax, Adjuvance Technologies and Sinovac Biotech.

When was Dynavax Technologies founded?

Dynavax Technologies was founded in 1996.

Where is Dynavax Technologies' headquarters located?

Dynavax Technologies' headquarters is located in Berkeley, CA, US.

When was Dynavax Technologies' last funding round?

Dynavax Technologies' most recent funding round was for $200M (USD) in May 2021.

How much has Dynavax Technologies raised to-date?

As of May 11, 2021, Dynavax Technologies has raised a total of $1.4B (USD).

How many employees does Dynavax Technologies have?

Dynavax Technologies has 351 employees as of Feb 6, 2024.

Dynavax Technologies - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Vaccines
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 15 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering